These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prolonged neuromuscular blockade with vecuronium in a neonate with renal failure. Haynes SR; Morton NS Anaesthesia; 1990 Sep; 45(9):743-5. PubMed ID: 1978607 [TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020 [TBL] [Abstract][Full Text] [Related]
6. Sustained Neuromuscular Blockade after Vecuronium Use in a Premature Infant. Sahni M; Richardson CJ; Jain SK AJP Rep; 2015 Oct; 5(2):e121-3. PubMed ID: 26495168 [TBL] [Abstract][Full Text] [Related]
7. Vecuronium neuromuscular blockade reflects liver function during hepatic autotransplantation in pigs. Pittet JF; Morel DR; Mentha G; Schopfer C; Belenger J; Benakis A; Tassonyi E Anesthesiology; 1994 Jul; 81(1):168-75. PubMed ID: 7913800 [TBL] [Abstract][Full Text] [Related]
8. Onset of vecuronium neuromuscular blockade at the hand with an arterio-venous shunt. Iwasaki H; Yamauchi M; Narimatsu E; Yamakage M; Tsuchida H; Namiki A Can J Anaesth; 1997 Nov; 44(11):1208-10. PubMed ID: 9398964 [TBL] [Abstract][Full Text] [Related]
9. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature. Watling SM; Dasta JF Crit Care Med; 1994 May; 22(5):884-93. PubMed ID: 7910130 [TBL] [Abstract][Full Text] [Related]
10. Sugammadex reverses neuromuscular block induced by 3-desacetyl-vecuronium, an active metabolite of vecuronium, in the anaesthetised rhesus monkey. Staals LM; van Egmond J; Driessen JJ; de Boer HD; van de Pol F; Bom AH; Booij LH Eur J Anaesthesiol; 2011 Apr; 28(4):265-72. PubMed ID: 21157358 [TBL] [Abstract][Full Text] [Related]
11. Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy? Geller TJ; Kaiboriboon K; Fenton GA; Hayat GR Neuromuscul Disord; 2001 Sep; 11(6-7):579-82. PubMed ID: 11525888 [TBL] [Abstract][Full Text] [Related]
12. [Protracted action of vecuronium in a patient with chronic renal insufficiency treated by dialysis]. Hackl W; Plainer B; Mauritz W Anaesthesist; 1988 Sep; 37(9):598-600. PubMed ID: 2903692 [TBL] [Abstract][Full Text] [Related]
13. Early recognition of risk factors for persistent effects of vecuronium. Sanders KA; Aucker R South Med J; 1996 Apr; 89(4):411-4. PubMed ID: 8614883 [TBL] [Abstract][Full Text] [Related]
14. Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants? Meretoja OA Br J Anaesth; 1989 Feb; 62(2):184-7. PubMed ID: 2564279 [TBL] [Abstract][Full Text] [Related]
15. Is vecuronium toxicity abolished by hemodialysis? A case report. Rollino C; Visetti E; Borsa S; Pignataro A; Pozzato M; Vallero A; Quarello F Artif Organs; 2000 May; 24(5):386-7. PubMed ID: 10848680 [TBL] [Abstract][Full Text] [Related]
16. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine. Gramstad L Br J Anaesth; 1987 Aug; 59(8):995-1003. PubMed ID: 2888477 [TBL] [Abstract][Full Text] [Related]
17. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia. Ma H; Zhuang X Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090 [TBL] [Abstract][Full Text] [Related]
18. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit. Burmester M; Mok Q Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895 [TBL] [Abstract][Full Text] [Related]
19. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients. Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324 [TBL] [Abstract][Full Text] [Related]
20. Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure. Bencini AF; Scaf AH; Sohn YJ; Meistelman C; Lienhart A; Kersten UW; Schwarz S; Agoston S Anesth Analg; 1986 Mar; 65(3):245-51. PubMed ID: 2869722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]